Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin Degludec, Insulin Glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin Degludec
  • Insulin Glargine
  • Anaheim, California
  • +80 more
Mar 9, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Huntsville, Alabama
  • +115 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Northridge, California
  • +98 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin aspart
  • insulin detemir
  • Birmingham, Alabama
  • +66 more
Jan 2, 2017

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +95 more
Dec 20, 2016

Diabetes, Diabetes, Type 2 Trial in Canada, Puerto Rico, United States (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Birmingham, Alabama
  • +77 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Canada, United States (liraglutide, rosiglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Goodyear, Arizona
  • +88 more
Jan 24, 2017

Diabetes, Type 2 Trial in Worldwide (BI 10773, Glimepiride, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +2 more
  • Phoenix, Arizona
  • +181 more
Jul 28, 2016

Diabetes, Type 2 Trial in Worldwide (Fasiglifam (TAK-875), Fasiglifam (TAK-875) Placebo, Sitagliptin)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Fasiglifam (TAK-875)
  • +4 more
  • Huntsville, Alabama
  • +103 more
Aug 26, 2015

Diabetes, Type 2 Trial in Worldwide (Placebo, empagliflozin (low dose qd), Empagliflozin (high dose qd))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo
  • +4 more
  • Florence, Alabama
  • +138 more
Jun 26, 2015

Diabetes, Type 2 Trial in Worldwide (Saxagliptin + Metformin, Placebo + Metformin, Pioglitazone)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Saxagliptin + Metformin
  • +2 more
  • Anniston, Alabama
  • +153 more
Apr 8, 2015

Diabetes, Type 2 Trial in Worldwide (LY2189265, Sitagliptin, Placebo solution)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Peoria, Arizona
  • +98 more
Mar 31, 2015

Diabetes, Type 2 Trial in Worldwide (Saxagliptin, Placebo matching Saxagliptin, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +134 more
Mar 16, 2015

Diabetes, Type 2 Trial in Worldwide (LY2189265, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +75 more
Jan 29, 2015

Diabetes, Type 2 Trial in Worldwide (Sitagliptin 100 mg, Canagliflozin 300 mg, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Sitagliptin 100 mg
  • +3 more
  • Mobile, Alabama
  • +183 more
Jan 5, 2015

Diabetes, Type 2 Trial in Worldwide (metformin , linagliptin , metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • metformin placebo
  • +3 more
  • Dhaka, Bangladesh
  • +89 more
Nov 13, 2014

Diabetes, Type 2 Trial in Worldwide (BI 10773, Placebo, Sitagliptin 100mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +2 more
  • Birmingham, Alabama
  • +242 more
Jul 14, 2014

Diabetes, Type 2 Trial in Worldwide (linagliptine 5 mg, linagliptine 5 mg and pioglitazone 30 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • linagliptine 5 mg
  • linagliptine 5 mg and pioglitazone 30 mg
  • Chula Vista, California
  • +231 more
Jun 18, 2014

Diabetes, Type 2 Trial in Worldwide (linagliptin low dose, , linagliptin medium dose)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • linagliptin low dose
  • +2 more
  • De Pinte, Belgium
  • +83 more
Jun 17, 2014

Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 10773 high dose, Placebo identical to BI 10773 low dose, BI 10773)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo identical to BI 10773 high dose
  • +2 more
  • Birmingham, Alabama
  • +147 more
May 16, 2014

Diabetes, Type 2, Renal Insufficiency Trial in Worldwide (BI 10773, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Renal Insufficiency
  • BI 10773
  • Placebo
  • Anaheim, California
  • +126 more
May 16, 2014

Diabetes, Type 2 Trial in Worldwide (metformin, linagliptin, metformin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +81 more
May 12, 2014

Action in Diabetes and Vascular Disease Preterax and Diamicron

Completed
  • Diabetes Mellitus, Type 2
    • Garran, Australian Capital Territory, Australia
    • +171 more
    May 15, 2014

    Diabetes, Type 2 Trial in Worldwide (Linagliptin + metformin, Linagliptin+metformin, Metformin)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Linagliptin + metformin
    • +2 more
    • Calgary, Alberta, Canada
    • +111 more
    Apr 29, 2014

    Diabetes, Type 2, Acute Coronary Syndrome Trial in Worldwide (Alogliptin, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Acute Coronary Syndrome
    • Birmingham, Alabama
    • +917 more
    Apr 15, 2014